Narrative review / 2015
Evidence for resveratrol's protective effects in humans remains inconsistent compared to animal data, with many clinical studies limited by small sample sizes.
Pre-clinical findings indicate that resveratrol may protect against various medical conditions and age-related complications. However, there is no consistent evidence of increased protection against metabolic disorders and other ailments when comparing animal and human studies. The review notes that most human studies examining resveratrol administration and patient outcomes have been limited by sample sizes. It evaluates advances in timing, dosage, formulation, bioavailability, toxicity, and drug interactions, as well as disease actions in cancer, diabetes, neurodegeneration, and cardiovascular disease.
- Study type
- Narrative review
- Who was studied
- Human clinical studies of resveratrol
- What was measured
- Effects on cancer, diabetes, neurodegeneration, cardiovascular disease, and other ailments
THE PAPER
Resveratrol supplementation: Where are we now and where should we go?
Novelle MG, Wahl D, Diéguez C, Bernier M, de Cabo R. Ageing Res Rev, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.